GlassScriptPhysician profile
Akarsh Parekh
NPI 1184156945
$14,951.02
in general payments reported to CMS, 2019-2025
35 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $997 · 2021: $2,080 · 2022: $3,722 · 2023: $3,389 · 2024: $4,405 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,989 · Travel and Lodging: $2,609 · Education: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,988.63 |
| Travel and Lodging | $2,609.39 |
| Education | $425.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,532.93 | 2020-2024 | Optis, Xience Skypoint, Ensite |
| Boston Scientific Corporation | $2,410.89 | 2021-2024 | Versacross Access Solution, Watchman Access System, Ranger |
| Inari Medical, INC. | $1,237.25 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $759.74 | 2020-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $588.58 | 2020-2025 | Lifevest |
| Philips North America LLC | $566.36 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $438.73 | 2020-2023 | Camzyos |
| Penumbra, INC. | $405.91 | 2023-2024 | Indigo System, Smart Coil |
| Bard Peripheral Vascular, INC. | $297.86 | 2021-2023 | Crosser Iq |
| Cardiovascular Systems INC. | $293.32 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $284.39 | 2019-2024 | Xarelto |
| Medtronic, INC. | $226.71 | 2021-2024 | Venaseal |
| Actelion Pharmaceuticals US, INC. | $219.69 | 2022-2024 | Uptravi, Opsumit |
| Shockwave Medical, INC | $218.39 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astellas Pharma US INC | $198.00 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $179.18 | 2023 | Barostim Neo System |
| Angiodynamics, INC. | $141.24 | 2023 | Alphavac |
| Zoll Circulation INC | $120.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.50 | 2024 | Jardiance |
| Ekos Corporation | $105.65 | 2019 | |
| Impulse Dynamics (USA) INC. | $103.18 | 2023 | Optimizer |
| Amgen INC. | $87.22 | 2022 | |
| Novartis Pharmaceuticals Corporation | $62.97 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $50.64 | 2022 | |
| Chiesi USA, INC. | $45.89 | 2023 | Kengreal, Cleviprex |
| Terumo Medical Corporation | $43.53 | 2020-2021 | |
| Cordis US Corp. | $38.62 | 2023-2025 | Mynx Control Venous, Zephyr |
| Cardiva Medical, INC. | $36.33 | 2025 | Optowire |
| Kestra Medical Technology Services, INC. | $30.00 | 2023 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $26.22 | 2021 | |
| United Therapeutics Corporation | $19.67 | 2024 | Tyvaso |
| Daiichi Sankyo INC. | $17.16 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $17.15 | 2022 | |
| Scpharmaceuticals INC. | $16.70 | 2023 | |
| Merck Sharp & Dohme LLC | $15.42 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akarsh Parekh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.